Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
515 studies found for:    Open Studies | "Uterine Diseases"
Show Display Options
Rank Status Study
1 Unknown  Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease
Condition: Benign or Preinvasive Uterine Disease
Interventions: Procedure: Single-port LAVH;   Procedure: Three-port LAVH
2 Recruiting Feasibility and Benefit of Laparoscopic Hysterectomy With Less Than 3 Millimeter Diameter's Instruments in Current Practice
Condition: Benign Uterine Diseases
Intervention: Procedure: laparoscopic hysterectomy
3 Not yet recruiting Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion
Conditions: Placenta Retained;   Uterine Diseases
Intervention: Device: intrauterine self-cross-linked hyaluronic acid gel
4 Not yet recruiting 3D Sonohysterography vs Hysteroscopy: Study for the Evaluation of Intrauterine Abnormalities
Condition: Uterine Diseases
Interventions: Device: diagnostic hysteroscopy;   Device: diagnostic sonar test
5 Recruiting Hysterectomy by Transabdominal Laparoscopy or NOTES
Condition: Uterine Diseases
Interventions: Procedure: vNOTES hysterectomy;   Procedure: LSC hysterectomy
6 Unknown  Study on Bladder and Sexual Function Change After Simple Hysterectomy
Condition: Benign Uterine Disease
Intervention:
7 Recruiting Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)
Conditions: Uterine Fibroids;   Adenomyosis
Intervention: Device: MRI-HIFU
8 Not yet recruiting Fast Versus Slow Tenaculum Placement
Conditions: IUD Insertion Complication;   Endometrial Diseases
Intervention: Procedure: Slow placement of the tenaculum
9 Recruiting Intrauterine Saline Washing for Detection Endometrial Disease in Patients With Abnormal Uterine Bleeding
Condition: Endometrial Disease
Interventions: Procedure: Endometrial saline plus curettage;   Procedure: Endometrial curettage
10 Not yet recruiting Carboplatin-cyclophosphamide Combined With Atezolizumab
Conditions: Breast Cancer;   Cervix Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: carbplatin, cyclophophamide, atezolizumab
11 Not yet recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
12 Not yet recruiting LLETZ Under Direct Colposcopic Vision
Condition: Uterine Cervical Dysplasia
Interventions: Device: LLETZ with colposcopy;   Other: LLETZ without colposcopy
13 Not yet recruiting Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment
Condition: Uterine Cervical Neoplasms
Intervention:
14 Not yet recruiting PET (Positron Emission Tomography) Imaging Studies With NIS Reporter
Conditions: Myeloma;   Endometrial Cancer
Intervention: Drug: BF4
15 Recruiting Irisin Hormone Levels in Endometrial Hyperplasia
Condition: Endometrial Hyperplasia
Intervention:
16 Not yet recruiting Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Conditions: Bleeding;   Implants;   Breakthrough Bleeding
Interventions: Drug: Tamoxifen;   Drug: Placebo
17 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
18 Not yet recruiting Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Condition: Recurrent Endometrial Cancer
Intervention: Drug: Pembrolizumab
19 Recruiting The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection
Condition: Uterine Cancer
Interventions: Drug: Dexmedetomidine group;   Drug: Control group
20 Recruiting Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers
Condition: Advanced Cervical Cancer
Intervention: Procedure: 'OSNA stadification during surgery'

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years